Anders Svenningsson

8.6k citations
110 papers · 5.4k indexed · 2 hit papers · h-index 38

Impact in

Papers in

Anders Svenningsson

107 papers receiving 5.2k citations

Hit Papers

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies 2019 · 346 citations
3462017202620202023100200300

Peers

Anders Svenningsson
Comparison fields: 5 of 110
  • Pathology and Forensic Medicine 3.4k
  • Neurology 1.7k
  • Developmental Neuroscience 324
  • Neurology 547
  • Immunology 1.2k
Replace Jan Lycke with:
Jan Lycke Sweden
Tobias Derfuß Switzerland
John Rose United States
Pierre Duquette Canada
Paolo Gallo Italy
Anthony T. Reder United States
Tania Kümpfel Germany
Ruggero Capra Italy
Florian Deisenhammer Austria
Markus Krumbholz Germany
Anders Svenningsson relative to Jan Lycke Sweden Jan Lycke's profile →
Citations per field
00.5×1.5×
Jan Lycke · 1×
Citations per year

Countries citing papers authored by Anders Svenningsson

Since Specialization
Citations

This map shows the geographic impact of Anders Svenningsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Svenningsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Svenningsson more than expected).

Fields of papers citing papers by Anders Svenningsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Svenningsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Svenningsson. The network helps show where Anders Svenningsson may publish in the future.

Co-authors

The 25 scholars most cited alongside Anders Svenningsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anders Svenningsson Line = papers co-authored together Anders Svenningsson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20244
3 20232
4 202316
5 20232
6 201926
7
Poor correlation between protein levels in different CNS compartments in patients with progressive MS
20191
8
Clinical effectiveness of dimethyl fumarate with focus on patients treated at least 36 months - a Swedish nationwide study of the long-term effectiveness and safety of dimethyl fumarate (IMSE5)
20191
9
Risk of hypogammaglobulinemia in long-term treatment with rituximab in multiple sclerosis
201910
10
A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5)
20184
11 201815
12 201726
13 201630
14
Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology
20152
15
A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and efficacy of natalizumab
20151
16 201546
17 2013102
18
The immunomodulation and multiple sclerosis epidemiology (IMSE) study; a Swedish nationwide pharmaco-epidemiological and genetic study focussed on long-term safety and efficacy of natalizumab (Tysabri)
20134
19 201251
20 199833

About Anders Svenningsson

Anders Svenningsson is a scholar working on Pathology and Forensic Medicine, Neurology, Immunology, Oncology and Developmental Neuroscience, having authored 110 papers that have together received 5.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (69 papers), Polyomavirus and related diseases (28 papers), Peripheral Neuropathies and Disorders (23 papers), Immunotherapy and Immune Responses (12 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.4k citations), Neurology (1.7k citations), Developmental Neuroscience (324 citations), Neurology (547 citations) and Immunology (1.2k citations). Anders Svenningsson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Peter Sundström, Fredrik Piehl, Jan Lycke, Jonatan Salzer, Martin Gunnarsson, Tomas Olsson, Markus Axelsson, Clas Malmeström, Mattias Vågberg and Henrik Zetterberg. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, Annals of Neurology, Journal of Neuroimmunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026